Education
About Us
Working with TipRanks
Follow Us
Medical Net,Inc. (JP:3645)
:3645
Top Page
Medical Net,Inc.
(3645)
Rating:62Neutral
Price Target:
¥336.00
▲(5.99%Upside)
Medical Net,Inc. (3645) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.79B
Dividend Yield0.95%
Average Volume (3M)29.93K
Price to Earnings (P/E)―
Beta (1Y)0.57
Revenue Growth19.56%
EPS Growth-906.44%
CountryJP
Employees289
SectorCommunication Services
Sector Strength90
IndustryInternet Content & Information
Share Statistics
EPS (TTM)-20.63
Shares Outstanding10,773,000
10 Day Avg. Volume14,930
30 Day Avg. Volume29,930
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medical Net,Inc. Business Overview & Revenue Model
Company DescriptionMedical Net, Inc. (3645) is a healthcare-focused company operating within the medical services sector. The company specializes in providing a range of healthcare solutions, including telemedicine services, healthcare consulting, and medical data management. Medical Net, Inc. aims to leverage technology to enhance the accessibility and efficiency of healthcare delivery, providing innovative solutions to both healthcare providers and patients.
How the Company Makes MoneyMedical Net, Inc. generates revenue through a multi-faceted business model that includes subscription fees for its telemedicine platform, consultancy fees for healthcare advisory services, and licensing fees for its medical data management solutions. The company partners with healthcare institutions, insurance companies, and independent practitioners to deliver comprehensive healthcare solutions. Additionally, collaborations with technology firms help enhance their service offerings, contributing to revenue growth. Key revenue streams are primarily from its telemedicine services, which provide ongoing subscription-based income, as well as one-time consultancy projects and data management contracts.
Medical Net,Inc. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 5.25B | 4.50B | 3.75B | 2.90B | 2.92B | Gross Profit |
| 1.84B | 1.78B | 1.46B | 1.18B | 972.40M | EBIT |
| 298.28M | 379.65M | 445.12M | 331.27M | 106.38M | EBITDA |
| 213.29M | 315.84M | 570.81M | 280.84M | 126.80M | Net Income Common Stockholders |
| 5.96M | 116.18M | 380.10M | 129.67M | 79.35M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 1.53B | 1.52B | 1.13B | 868.66M | 605.27M | Total Assets |
| 3.99B | 3.47B | 3.15B | 2.11B | 1.74B | Total Debt |
| 1.03B | 790.83M | 773.54M | 383.31M | 411.19M | Net Debt |
| -498.82M | -727.72M | -360.45M | -485.35M | -194.09M | Total Liabilities |
| 2.06B | 1.54B | 1.42B | 846.98M | 730.18M | Stockholders Equity |
| 1.91B | 1.92B | 1.70B | 1.24B | 996.49M |
| Cash Flow | Free Cash Flow | |||
| 86.79M | 408.50M | 340.39M | 378.84M | 69.56M | Operating Cash Flow |
| 119.59M | 429.13M | 342.55M | 391.87M | 78.29M | Investing Cash Flow |
| -285.40M | -62.37M | -355.11M | -87.99M | -14.60M | Financing Cash Flow |
| 144.11M | -17.90M | 282.23M | -34.03M | -497.40M |
Medical Net,Inc. Technical Analysis
Negative
317.00
Price Trends
311.73
Positive
313.37
Positive
318.51
Negative
Market Momentum
2.29
Positive
45.42
Neutral
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3645, the sentiment is Negative. The current price of 317 is below the 20-day moving average (MA) of 321.68, above the 50-day MA of 311.73, and below the 200-day MA of 318.51, indicating a neutral trend. The MACD of 2.29 indicates Positive momentum. The RSI at 45.42 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3645.
Medical Net,Inc. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | ¥2.79B | ― | 0.95% | 19.56% | -906.44% | ||
61 Neutral | $14.28B | 5.89 | -4.20% | 3.70% | 2.73% | -35.75% | |
57 Neutral | ¥3.43B | 3,633.15 | ― | 14.51% | 84.03% | ||
54 Neutral | ¥2.20B | ― | ― | -22.04% | -9.95% | ||
51 Neutral | ¥2.41B | ― | ― | -12.25% | -142.67% | ||
41 Neutral | ¥1.82B | ― | ― | -29.86% | -88.54% |
* Communication Services Sector Average
Performance Comparison
JP:3645
Medical Net,Inc.
314.00
-50.64
-13.89%
JP:2459
AUN Consulting, Inc.
234.00
19.00
8.84%
JP:3691
DIGITAL PLUS, Inc.
801.00
287.00
55.84%
JP:3845
I-Freek Mobile Inc.
97.00
5.00
5.43%
JP:3985
Temona, Inc.
229.00
14.00
6.51%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.